Navigation Links
eDiets.com(R) Announces Q4 and Year End 2007 Results
Date:3/4/2008

and expenses:

Cost of revenue 2,136 1,942 7,222 9,622

Technology and development 949 977 3,723 3,203

Sales, marketing and support 3,242 4,564 17,029 30,445

General and administrative 1,751 1,851 6,984 8,549

Amortization of intangibles 305 301 1,213 760

Impairment of goodwill and

intangible assets 2,296 - 2,296 -

Total cost and expenses 10,679 9,635 38,467 52,579

Loss from continuing

operations (3,779) (90) (8,738) (3,765)

Other (expense) income, net (459) 34 (499) 184

Income tax benefit (provision) 26 (12) (171) (66)

Net loss from continuing

operations (4,212) (68) (9,408) (3,647)

Discontinued Operations:

Loss from operations, net

of tax - (60) - (412)

Loss on disposal, net of

tax - (81) - (41)

Loss from discontinued

operations, net of tax - (141) - (453)

Net loss $(4,212) $(209) $(9,408) $(4,100)

Basic loss per common share:

Loss from continuing

operations $(0.17) $(0.00) $(0.38) $(0.16)

Loss from discontinued

operations - (0.01) - (0.02)

Net loss $(0.17) $(0.01) $(0.38) $(0.18)

Diluted loss per common share:

Loss from continuing

operations $(0.17) $(0.00) $(0.38) $(0.16)

Loss from discontinued

operations -
'/>"/>

SOURCE eDiets.com, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. eDiets.com(R) Updates Timing of Third Quarter 2007 Earnings Conference Call
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 2Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 3Chinese-American Women & Korean-American Women at Highest Risk for Developing Diabetes During Pregnancy 4Within3 Expands into Mobile Applications 2RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 1The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 2The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 3The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 4The American Medical Money Machine the Destruction of Healthcare in America and the Rise of Medical Tourism a New Book by James R Goldberg 60129 5Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 1Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 2Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy According to HealthCore Study Presented at 5722 3UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 1UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 2UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 3
Other Medicine Technology:DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 2DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education 3Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 2Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 3Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 4Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 5Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease 6